Tuesday, October 25, 2016

US FDA News: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence

New Warning and updated Abuse and Dependence sections of labeling, including new safety information from published literature and case reports.
Read more: Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence